Vyleesi for Low Sex Drive – On‑Demand Desire Booster Therapy

Vyleesi: The “On-Demand Desire Booster”

Imagine being able to choose when your desire kicks in — a boost exactly when you want it, not a daily commitment. That’s the promise of Vyleesi, the first FDA-approved as-needed therapy for low sexual desire in premenopausal women. It’s designed to help women reclaim intimacy, confidence, and connection with their partners.

How Vyleesi Works

Vyleesi is a subcutaneous injection that you administer about 45 minutes before sexual activity. Unlike ED medications, which work on blood flow, Vyleesi targets brain pathways that influence sexual motivation and desire. This makes it a unique option for women whose low sexual desire is not caused by relationship issues, stress, or medication side effects, but arises as an acquired, generalized condition.

Key points about how it works:

• Acts on melanocortin receptors in the brain, helping restore sexual desire.
• Designed for premenopausal women with distressing low sexual desire.
• Flexible and on-demand: you decide when to use it — no daily pills required.

Side effects can include nausea, flushing, headache, injection site reactions, and temporary increases in blood pressure. It’s recommended to use no more than one injection per 24 hours, and no more than eight injections per month.

Vyleesi and Men

Officially, Vyleesi is not approved for men. However, its active ingredient, Bremelanotide (PT-141), has been studied in men in early clinical trials and real-world observations:

• Clinical trials: Intranasal Bremelanotide showed improvements in arousal and erectile response for some men, particularly those who did not respond to standard ED medications.
• Observational reports: Off-label use of subcutaneous Bremelanotide in men with low libido or psychological sexual dysfunction showed promising improvements in sexual motivation and overall sexual function.

Important considerations for men:

• Use in men is experimental and off-label.
• Side effects can include nausea, flushing, headache, and temporary increases in blood pressure.
• Men with cardiovascular conditions should avoid unsupervised use.

While not officially approved, these early studies suggest Bremelanotide may benefit men whose sexual challenges are linked to motivation or arousal rather than blood flow.

Who Might Benefit

• Women: Premenopausal women diagnosed with acquired, generalized low sexual desire that causes distress.
• Men (off-label/experimental use): Men with libido or arousal challenges not caused by vascular problems, and under medical supervision.

Vyleesi is not a performance enhancer, and it does not treat erectile dysfunction or guarantee “supercharged” sexual activity. Its focus is desire, motivation, and arousal — the psychological spark that often underpins a satisfying sexual experience.

Why Vyleesi is Unique

Vyleesi stands out because it:

• Works on-demand, rather than requiring daily administration.
• Targets the central nervous system, rather than vascular mechanisms.
• Offers a non-hormonal option for women experiencing distressing low desire.
• Shows early potential in men, although this remains off-label and requires medical supervision.

The Bottom Line

Vyleesi is an exciting, first-of-its-kind therapy that can help premenopausal women regain desire and intimacy. For men, the evidence is preliminary but intriguing — especially for those whose sexual challenges are psychological or arousal-based rather than physical.

Book your consultation today at PULSE Clinic Thailand

Take the first step toward feeling alive, confident, and connected again.